Influence of Gut Microbiome in Gallstone Disease
Understanding Changes in the Gut Microbiome in Patients With Gallstone Disease and Its Impact on Patient Outcomes
1 other identifier
observational
75
1 country
1
Brief Summary
The goal of this prospective observational study is to explore the role of the gut microbiome in patients with gallstone disease. The main question\[s\] it aims to answer are:
- if there is a relationship between the gut microbiome and the development of complications associated with gallstone disease (such as pancreatitis and acute cholecystitis)
- if there are changes in the gut microbiome following cholecystectomy and the relationship with patient outcomes. Participants will be asked to provide stool samples at fixed time points (recruitment, pre- and post-cholecystectomy if applicable and at 6 months and 3 years. They will also be asked to provide stool samples if they represent to hospital with complications associated with their gallstone disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2023
CompletedFirst Posted
Study publicly available on registry
February 17, 2023
CompletedStudy Start
First participant enrolled
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 13, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 13, 2026
ExpectedFebruary 23, 2024
February 1, 2024
2.5 years
February 7, 2023
February 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Bacterial DNA profile
The diversity of species present in the stool of participants
through study completion, up to 3 years from cholecystectomy
Eligibility Criteria
Patients with gallstone disease presenting to an East Kent University Foundation Trust Hospital
You may qualify if:
- All adults (age \>18 years of age) patients diagnosed with gallstone disease following confirmatory imaging at an East Kent University Foundation Trust Hospital. Patients of any gender, ethnicity or socio-economic background are eligible as well as pregnant women. Patients undergoing both open and laparoscopic cholecystectomy will be included.
You may not qualify if:
- Patients less than 18 years of age and patients who do not have capacity to consent to involvement in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
EKHUFT
Ashford, Kent, TN24 0LZ, United Kingdom
Biospecimen
We are collecting stool samples to analyse bacterial DNA however patient DNA will also be present in these samples. Samples will be destroyed at the end of the study.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2023
First Posted
February 17, 2023
Study Start
May 30, 2023
Primary Completion
November 13, 2025
Study Completion (Estimated)
November 13, 2026
Last Updated
February 23, 2024
Record last verified: 2024-02